Early and late direct costs in a Southern African antiretroviral treatment programme: a retrospective cohort analysis.
| Autor: | Rory Leisegang, Susan Cleary, Michael Hislop, Alistair Davidse, Leon Regensberg, Francesca Little, Gary Maartens |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2009 |
| Předmět: | |
| Zdroj: | PLoS Medicine, Vol 6, Iss 12, p e1000189 (2009) |
| Druh dokumentu: | article |
| ISSN: | 1549-1277 1549-1676 |
| DOI: | 10.1371/journal.pmed.1000189 |
| Popis: | BACKGROUND: There is a paucity of data on the health care costs of antiretroviral therapy (ART) programmes in Africa. Our objectives were to describe the direct heath care costs and establish the cost drivers over time in an HIV managed care programme in Southern Africa. METHODS/FINDINGS: We analysed the direct costs of treating HIV-infected adults enrolled in the managed care programme from 3 years before starting non-nucleoside reverse transcriptase inhibitor-based ART up to 5 years afterwards. The CD4 cell count criterion for starting ART was |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|